- Haemolytic anemia in patients treated with ribavirine - clinical experience and treatment2007 | Third Faculty of Medicine
- Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences2010 | Faculty of Science
- Efficacy of therapy with pegylated interferon and ribavirin in patients with chronic HCV infection.2009 | First Faculty of Medicine
- Combination Therapy with Interferon alpha-2b and Ribavirin of Patients with Chronic Hepatitis C - Results of Czech Multicentre trial2002 | First Faculty of Medicine, Central Library of Charles University
- Why is the Response to Combination Therapy with Interferon Alpha 2b and Ribavirin in Chronic Hepatitic so Poor2002 | First Faculty of Medicine
- Report of University Hospital Hradec Králové to the clinical trial protocol No. AI452-020-0030Publication without faculty affiliation
- Efficacy and safety of peginterferon alpha-2a (40KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe2011 | First Faculty of Medicine
- Combination therapy by alfa-2b and ribavirin in patients with chronic hepatitis C - results of the Czech multicentric studyPublication without faculty affiliation
- Transport of ribavirin across the rat and human placental barrier: roles of nucleoside and ATP-binding cassette drug efflux transporters2019 | Faculty of Pharmacy in Hradec Králové
- Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response2010 | Faculty of Medicine in Pilsen
- Treatment of chronic hepatitis C - refractory forms2014 | First Faculty of Medicine
- Viral hemorrhagic fevers2013 | Faculty of Medicine in Hradec Králové
- Infections caused by respiratory syncytial viruses - epidemiology, clinical picture, diagnosis, prevention and treatment options2023 | Second Faculty of Medicine
- Telaprevir2012 | Faculty of Medicine in Pilsen
- Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone2009 | Second Faculty of Medicine
- Adverse effects of telaprevir treatment and their management2013 | Faculty of Medicine in Pilsen
- Analysis of the immunomodilatory activity of levovorin, a second generation ribavirin analogue, on T-cell responses to hepatitis C virusPublication without faculty affiliation
- Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial2016 | First Faculty of Medicine
- Production of interleukins 10 and 12 by activated peripheral blood monocytes/macrophages in patients suffering from chronic hepatitis C virus infection with respect to the response to interferon and ribavirin treatment2002 | First Faculty of Medicine
- Production of interleukins 10 and 12 by activated peripheral blood monocytes/macrophages in patients suffering from chronic hepatitis C virus infection with respect to the response to interferon and ribavirin treatment2002 | Faculty of Physical Education and Sport
- Immunological predictors of different responses to combination therapy with interferon alfa and ribavirin in patients with chronic hepatitis C2003 | First Faculty of Medicine
- Immunological predictors of different responses to combination therapy with interferon alfa and ribavirin in patients with chronic hepatitis C2003 | Faculty of Physical Education and Sport
- Guidelines for diagnostic and therapeutical approach to patients with chronic HCV infection.2008 | First Faculty of Medicine
- Efficacy and safety of interferon alfa-2b and ribavirin combination therapy in chronic hepatitis C patients: A Czech multicenter studyPublication without faculty affiliation
- Efficacy of daily interfero-alfa in combination with ribavirin in the treatment of naive patients with chronic hepatitis CPublication without faculty affiliation
- In vitro susceptibility of adenovirus to antiviral drugs in species-dependent2005 | Second Faculty of Medicine
- Viral hepatitis C and metabolic syndrome2010 | Third Faculty of Medicine
- Průběžná analýza FÁZE 2B (týden 12) výsledků léčby albumin interferonem alfa-2B v kombinaci s ribavirinem u chornické infekce virem hepatitidy C genotypu 1Publication without faculty affiliation
- Therapy of chronic viral hepatitis B and C and evidence based medicine2008 | First Faculty of Medicine
- Large randomised clinical trials and regular practice in a tertiary hepatology centre.2008 | First Faculty of Medicine